| Thu, Dec 3, 2009 | | | ABT Settles TriCor Dispute with Teva Zacks.com (Thu, Dec 3)
| | Wed, Dec 2, 2009 | | | Impax buys applications for 2 Watson generics AP (Wed, Dec 2)
| | | Impax Laboratories Acquires Rights to Abbreviated New Drug Applications Business Wire (Wed, Dec 2)
| | Tue, Dec 1, 2009 | | | Abbott Makes All the Right Moves at Motley Fool (Tue, Dec 1)
| | Tue, Nov 24, 2009 | | | Global Pharmaceuticals Awards Grant to Myasthenia Gravis Alliance Business Wire (Tue, Nov 24)
| | Fri, Nov 20, 2009 | | | Impax Laboratories Drives Stronger Performance with IBM Business Analytics PR Newswire (Fri, Nov 20)
| | Mon, Nov 16, 2009 | | | Developments for Parkinson's Disease Ignite Investor Enthusiasm at Seeking Alpha (Mon, Nov 16)
| | Tue, Nov 10, 2009 | | | Impax Laboratories to Present at the Credit Suisse 18th Annual Healthcare Conference Business Wire (Tue, Nov 10)
| | | IMPAX LABORATORIES INC Financials EDGAR Online Financials (Tue, Nov 10)
| | Fri, Nov 6, 2009 | | | Biosimilars, Biologics, Biotech And Specialty Pharmaceuticals: Piper Jaffray Picks The Stocks And Sectors With Highest Potential Returns For Investors Wall Street Transcript (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | | [$$] Should You Buy It? Impax Labs at RealMoney by TheStreet.com (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | | IMPAX LABORATORIES INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Wed, Nov 4)
| | | New Star Analyst Rankings for Impax Laboratories, Inc. StarMine (Wed, Nov 4)
| | Tue, Nov 3, 2009 | | | Impax swings to Q3 profit at bizjournals.com (Tue, Nov 3)
| | | Impax Laboratories Earnings Call scheduled for 11:00 am ET today CCBN (Tue, Nov 3)
| | | IMPAX LABORATORIES INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online (Tue, Nov 3)
| | | Impax Laboratories Continues Trend of Solid Growth in Revenue, Profit and Earnings for the Third Quarter 2009 Business Wire (Tue, Nov 3)
| | | Q3 2009 Impax Laboratories Earnings Release - Before Market Open CCBN (Tue, Nov 3)
| | Fri, Oct 30, 2009 | | | Abbott suing Impax Labs over generic TriCor AP (Fri, Oct 30)
| | | Impax Laboratories Confirms Patent Challenge Relating to TRICORĀ® 48mg and 145mg Tablets Business Wire (Fri, Oct 30)
| Add IPXL News to My Yahoo!:

| |
|